Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

CELZ stock hub

Creative Medical Technology Holdings, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CELZis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

8.5M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

CELZ

In the news

Latest news · CELZ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-81.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-52.2

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CELZ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001187953
Company name	Creative Medical Technology Holdings, Inc.
Country	United States
Country code	US
Cusip	22529Y200
Employees	4
Employees Change	0%
Employees Change Percent	0
Enterprise value	$2.7M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US22529Y4089
Last refreshed	2026-05-10
Market cap	$8.5M
Market cap category	Nano-Cap
Price	$2.31
Price currency	USD
Rev Per Employee	750x
Sector	Healthcare
Sic	2836
Symbol	CELZ
Website	https://www.creativemedicaltechnology.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-67.48%
EV/Sales	901.77x
P/B ratio	1.4x
P/S ratio	2,846.43x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	66.87%
Gross Profit	$2,006
Gross Profit Growth	-76.12%
Gross Profit Growth3 Y	-66.19%
Gross Profit Growth5 Y	-52.84%
Net Income	$-5.8M
Net Income Growth Quarters	1%
Net Income Growth Years	0%
Pretax Margin	-192,020.93%
Profit Per Employee	$-1.4M
ROA	-50.22
Roa5y	-38.5
ROCE	-96.88
ROE	-81.17
ROIC	-52.22

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	19.7%
Cagr3y	-28.79%
Cagr5y	-58.04%
EPS Growth Quarters	4
EPS Growth Years	3
Revenue Growth	-78.57x
Revenue Growth Years	0x
Revenue Growth3 Y	-65.59x
Revenue Growth5 Y	-52.37x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$6.4M
Cash	$5.8M
Current Assets	$6.1M
Current Liabilities	$307,649
Debt	$14,194
Debt Equity	$0
Equity	$6.1M
Liabilities	$307,649
Long Term Assets	$381,658
Long Term Liabilities	$0
Net Cash	$5.8M
Net Cash By Market Cap	$68.32
Net Cash Growth	-24.12%
Net Debt Equity	$-0.95
Tangible Book Value	$5.7M
Tangible Book Value Per Share	$1.55
WACC	14.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	19.69
Net Working Capital	$-82,712
Quick ratio	19.01
Working Capital	$5.8M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-73.62%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	19.69%
200-day SMA	2.61
3Y total return	-63.91%
50-day SMA	2.07
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.7%
All Time High	525,013.1
All Time High Change	-100%
All Time High Date	2017-04-05
All Time Low	1.5
All Time Low Change	53.59%
All Time Low Date	2025-12-29
ATR	0.16
Beta	1.85
Beta1y	1.36
Beta2y	0.76
Ch YTD	17.86
High	2.38
High52	6.25
High52 Date	2025-10-28
High52ch	-63.04%
Low	2.1
Low52	1.5
Low52 Date	2025-12-29
Low52ch	53.59%
Ma50ch	11.54%
Premarket Change Percent	-2.62
Premarket Price	$2.23
Premarket Volume	1,061
Price vs 200-day SMA	-11.6%
RSI	58.36
RSI Monthly	33.34
RSI Weekly	50.39
Sharpe ratio	0.63x
Sortino ratio	1
Total Return	-73.62%
Tr YTD	17.86
Tr1m	2.67%
Tr1w	3.13%
Tr3m	19.69%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Earnings EPS Estimate	$-0.39
Operating Income	$-5.9M
Operating margin	-198,049.6

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	3,431,396%
Float Percent	92.82%
Shares Insiders	0.34%
Shares Institutions	7.15%
Shares Out	3,696,668
Shares Qo Q	37.9%
Shares Yo Y	73.62%
Short Float	4.57%
Short Ratio	2.46
Short Shares	4.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	66,355.1x
Bv Per Share	1.65
Ch1m	2.67
Ch1w	3.13
Ch1y	19.69
Ch3m	19.69
Ch3y	-63.91
Ch5y	-98.7
Ch6m	-23.51
Change	0.87%
Change From Open	0.43
Close	2.29
Days Gap	0.44
Depreciation Amortization	121,605
Dollar Volume	157,562.8
Earnings Date	2026-05-08
Earnings Time	amc
EBIT	$-5.9M
EBITDA	$-5.8M
EPS	$-2.05
F Score	2
Financing CF	3,834,029
Fiscal Year End	December
Founded	1,998
Investing CF	-225,500
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Date	2023-06-12
Last Split Type	Reverse
Last10k Filing Date	2026-03-20
Ma150	2.41
Ma150ch	-4.27%
Ma20	2.26
Ma20ch	2.12%
Net CF	-1,979,691
Next Earnings Date	2026-08-07
Open	2.3
Optionable	No
Position In Range	75
Post Close	2.31
Postmarket Change Percent	-5.95
Postmarket Price	$2.17
Pre Close	2.29
Price Date	2026-05-08
Ptbv Ratio	1.49
Relative Volume	1.03x
Revenue	3,000x
Tr6m	-23.51%
Us State	Arizona
Volume	68,209

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CELZ pay a dividend?

Capital-return profile for this ticker.

Performance

CELZ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CELZ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.2%

Float: +92.8% of shares outstanding

Insider ownership

+0.3%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

CELZ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.4

Neutral momentum band

Price vs 200-day MA

-11.6%

50/200-day relationship not available

Beta (5Y)

1.85

More volatile than the market

Sharpe ratio

0.63

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CELZ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current CELZ stock rating?

Creative Medical Technology Holdings, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full CELZ analysis?

The full report lives at /stocks/CELZ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for CELZ?

The latest report frames CELZ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the CELZ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.